Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Alzheimer's    crawled date : 2021 - 11 - 10    save search

AC Immune Alzheimer’s Drug Reduces Cognitive Decline but Misses Functional En...
Published: 2021-11-10 (Crawled : 21:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.09% H: 1.42% C: 1.07%

alzheimer drug alzheimer’s alzheimer's
AC Immune Alzheimer’s Drug Reduces Cognitive Decline but Misses Functional Endpoints
Published: 2021-11-10 (Crawled : 21:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.09% H: 1.42% C: 1.07%

alzheimer drug alzheimer’s alzheimer's
Eisai Presents Late-Breaker Updates On Lecanemab Clinical, Biomarker And Safety Data From Phase 2b Study Core And Open-Label Extension Across Five Years At Clinical Trials On Alzheimer's Disease (CTAD) Conference
Published: 2021-11-10 (Crawled : 21:00) - biospace.com/
BIIB | $193.18 -0.48% -0.48% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.44% C: -1.15%

disease alzheimer ema phase 2 clinical trials trials phase 2b trial conference alzheimer’s alzheimer's disease alzheimer's biomarkers lecanemab
Athira Pharma Presents Overview and Update from ACT-AD and LIFT-AD Trials of ATH-1017 in mild-to-moderate Alzheimer’s Disease at CTAD Conference
Published: 2021-11-10 (Crawled : 17:00) - globenewswire.com
ATHA | $2.035 -2.63% -2.7% 85K twitter stocktwits trandingview |
Health Technology
| | O: -0.65% H: 2.92% C: -3.51%

disease alzheimer ath-1017 trials trial conference alzheimer’s alzheimer's disease alzheimer's
Anavex Life Sciences Announces Participation at Upcoming Lausanne VIII Workshop Panel - Building Global Momentum for Interventions in Alzheimer’s Disease
Published: 2021-11-10 (Crawled : 12:15) - globenewswire.com
AVXL | $3.68 0.0% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: -7.28% H: 3.35% C: -1.43%

disease alzheimer life science anavex alzheimer’s alzheimer's disease alzheimer's
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.